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Paediatric Reference Values for Urinary Catecholamine Metabolites
Evaluated by High Performance Liquid Chromatography and
Electrochemical Detection1)
Nora Marchese, Silvana Canini, Laura Fabi and Luciano Famularo
l°Laboratorio di Analisi Chimico-Cliniche, Istituto Giannina Gaslini, Genova, Italy
Summary: The majority of the published reference range data on catecholamines excretion by healthy children is
incomplete and often contradictory (1). We assayed in the urines of 127 healthy children the values of the catechola-
mines (norepinephrine, epinephrine, dopamine) and their methylated metabolites (normetanephrine, metanephrine,
3-methoxytyramine) for the determination of paediatric reference ranges. Data were expressed as μg/24 h, μηαοΙ/24 h
and mmol/mol creatinine. An isocratic HPLC procedure by ion-pair reversed phase chromatography on a C18
column, using a single mobile phase containing formic acid, acetonitrile, diethylamine and octane sulphonic acid
(ion pairing agent), permitted the separate assay of the various fractions of total catecholamines. The relations
between each biogenic amine and age were studied and reference values were determined as a function of age.
Introduction
Neural crest tumours such as neuroblastoma and
ganglioneuroma are associated with an abnormal secre-
tion of catecholamines in tissue and body fluids. Assays
of urinary vanillylmandelic acid, homovanillic acid, and
dopamine permit biochemical diagnosis of neuro-
blastoma in approximately 80% of patients (2).
Differential diagnosis of phaeochromocytoma, neuro-
blastoma and related diseases requires multiple investi-
gations, among which the determination of the catechol-
amines and of their metabolites is of primary impor-
tance (3).
Catecholamines are compounds containing aliphatic
amines attached to a benzene ring bearing two hydroxyl
groups in 3,4 position (catechol). They are derivatives
of the amino acid tyrosine. Catecholamines are exten-
sively metabolized; only 2—10% are eliminated in urine,
the major part in conjugated form, and less than 20%
are eliminated as methylated metabolites (essentially
conjugated): normetanephrine, metanephrine and 3-me-
thoxytyramine. Norepinephrine is the main neurotrans-
mitter of the autonomic nervous system, dopamine is
both a precursor of norepinephrine and a neuromediator
of the central nervous system. The adrenal medulla con-
tains norepinephrine N-methyltransferase, which con-
verts norepinephrine into epinephrine. The catechola-
mine metabolic pathways are illustrated in figure 1.
High-performance liquid chromatography with ampero-
metric detector (HPLC-EC) methods allows the separate
assay of various catecholamine fractions: norepineph-
rine, epinephrine, dopamine, normetanephrine, meta-
nephrine, 3-methoxytyramine (4).
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Fig. 1 Catecholamine pathways.
MAO: monoamine oxidase; COMT: catechol-O-methyl transferase
[Modified from Candito M. et al. (3)]
The underlined compounds are those assayed in our laboratory.
534 Marchese et al.: Paediatric reference values for urinary catecholamine metabolites
Materials and Methods
Sample collection
Twenty-four-hour urine specimens were collected in polyethylene
boxes containing 4 ml per litre of an acidic buffer mixture of
CH3 COOH 4 mol/1/NaOH 4 mol/1 (4 + 1, by vol.) as preservative.
The volume of the specimen was measured; an aliquot was stored
at —20 °C. Normal reference values were calculated on 127 healthy
children aged 21 days to 14 years (mean: 50 months, median: 36
months): some of them were from the school and some were out-
side or inside patients without specific symptoms of hypertension.
All the above-mentioned compounds were assayed in the urine of
children before any treatment.
Analytical methods
Creatinine values were measured by the Jaffe method (5) on the
Synchron CX7 (Beckman Instruments, Inc. Brea, CA 92621-
6209).
For the determination of total (free and conjugated) concentrations
of catecholamines, the urine samples were hydrolyzed. To 1 ml
urine and 250 μΐ of internal standard (dihydroxybenzylamine) HC1
concentrated to pH l was added and then heated to 100 °C in a
closed tube for 20 minutes (6). After hydrolysis, the pH of the
mixture was adjusted to 6.5 with 2 mol/1 and 0.5 mol/1 NaOH suc-
cessively. The urine neutralised was purified by a cation exchange
column of resin Amberlite CG 50 (Acros Organics, New Jersey,
USA); the biogenic amines were eluted with 5ml of 0.1 mol/1
nitric acid. The eluate (20—50 μΐ) was injected into the HPLC
system (4,6).
HPLC-EC was performed on a 125 mm X 4 mm i. d. LichroCART-
Superspher 100 RP-18 (E. Merck, Darmstadt, Germany) column
filled with 5 μηι particle size. A similar pre column (LiChrocart 4-
4) was used.
The system was automated with an autosampler model ISS 100
(Perkin Elmer Corporation, Norwalk, USA). The results were pro-
cessed by a computing integrator model LCI00 (Perkin Elmer).
Mobile phase: Formic acid (100 nmol/l)/citric acid (1 mmol/l)/oc-
tane sulphonic acid (0.4 mmol/l)/ethylenediaminotetraacetic acid
(EDTA) (0.1 nmol/1) and 5% acetonitrile, diethylamine (0.25%),
pH 3.1 with KOH 0.5 mol/1.
Flow rate: 0.7 ml/min isocratic
Detection: 750 mV by model LC 4C electrochemical detector
(BAS, Indiana, USA).
Statistical methods
The correlation among biogenic amines and between each cate-
cholamine and age was investigated by non-parametric Spearman
test.
When the population had a Gaussian distribution, reference limits
were determined by a linear regression as a function of the chil-
drens age.
If data distribution was not normal, the different groups were com-
pared by Kruskal-Wallis test.
Results
Analytical results
Intra- and inter-assay imprecisions were determined
from analysis of Ortho and Biorad normal and patholog-
ical control urines and from a normal urine.
Infra-assay coefficients of variation (CV) were: 10.5%
for norepinephrine, 9.5% for epinephrine, 6% for dopa-
mine, 7% for metanephrine, 8.5% for normetanephrine
and 5% for 3-methoxytyramine. Inter-assay CVs were:
13.5% for norepinephrine, 10.5% for epinephrine, 5%
for dopamine and 3-methoxytyramine, 6% for meta-
nephrine and normetanephrine.
Recoveries were different: 90% for norepinephrine, 89%
for epinephrine, metanephrine and normetanephrine,
102% for dopamine and 92% for 3-methoxytyramine.
We had a good linearity from 50 pg to 100 ng of norepi-
nephrine with less than 5% deviation from the fit line.
The determination of the lower detection limits of the
components was based on the linear dilution of their
standards. The detection limits were 9 nmol/1 for norepi-
nephrine, 11.5 nmol/1 for epinephrine, 11.9 nmol/1 for
dopamine, 11 nmol/1 for metanephrine and 11.3 nmol/1
for normetanephrine and 7.1 nmol/1 for 3-methoxytyra-
mine, using 50 μΐ injection volume of a standard solu-
tion and of an Ortho normal control urine appropriately
diluted.
Statistical results
Different catecholamine metabolites were poorly corre-
lated among themselves: this event demonstrated a dif-
ferent information provided by each analyte.
All biogenic amine levels, except normetanephrine, were
strictly related to age (r = about 0.7). Therefore it was
necessary to express reference values in relation with
patient age.
If the values were calculated as μg/24 h or μηιοΙ/24 h,
they appeared with no Gaussian distribution even after
logarithmic transformation. On the contrary these values
showed a normal distribution if they were expressed as
mmol/mol creatinine and transformed in natural loga-
rithm.
Opportune age intervals that appeared significantly dif-
ferent were determined for epinephrine, norepinephrine,
dopamine, normetanephrine, metanephrine, and 3-me-
thoxytyramine levels calculated as μ^241ι and μπιοί/
24 h. These intervals are graphically illustrated in fig-
ure 2.
Table 1 reports upper reference limits and their confi-
dence intervals.
The relations between childrens age and the different
catecholamine metabolites expressed as mmol/mol cre-
atinine are reported in figure 3 as linear regressions.
Their upper reference limits are also graphically il-
lustrated in figure 3.
Discussion
The analytical method appeared easy and reproducible.
These reference ranges were established in agreement
with International Federation Clinical Chemistry (IFCC)
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Norepinephrine 0 — 2
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9-14
Epinephrine 0— 2
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Catecholamine Catecholamine
Concentration Confidence Concentration Confidence
intervals intervals
(μ&/241ι) (Hg/24h) (μηιο1/24^ (umoy24h)
<274 247- 301 <1.62 1.46- 1.78
<590 579- 601 <3.50 3.42- 3.55
<680 519- 841 <4.02 3.07- 4.97
<38 35- 41 <0.21 0.19- 0.22
<150 139- 161 <0.82 0.76- 0.88
<360 291- 428 <1.97 1.59- 2.34
<827 326- 878 <4.52 1.78- 4.79
<1300 1240-1360 <8.49 8.10- 8.88
<1876 1663-1989 <12.25 10.89-12.98
<254 238- 270 <1.29 1.21- 1.37
<461 433- 489 <2.34 2.19- 2.48
<103 94-112 <0.62 0.56-0.67
<210 192-228 <1.26 1.15-1.36
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Fig. 3 Linear regressions.
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recommendations (7) and the data were described with
an adequate graphic, preceded and complemented by a
formal statistical analysis (8). We carefully selected lo-
cal healthy children among our population.
Our reference values, with the exception of 3-methoxy-
tyramine, are higher than those reported in the literature
(1, 3); the increase of catecholamine excretion with age
was already reported (9).
Many factors influence the large variation in published
paediatric reference ranges for urine metabolites of cate-
cholamines (1). There is no uniformity in the units re-
ported from different laboratories. Data were expressed as
mmol/mol creatinine, mmol/day or mmol/kg body weight
with no possibility of comparing results (10—12).
We chose to evaluate the total catecholamines (free and
conjugated) with a published method (6) improving only
the detection of these compounds with the use of an
amperometric detector (4).
We assayed the total catecholamines because this way
the information on the metabolism is more complete and
the data give better information about the lowest varia-
tion of the excretion of the tumour (3). We had a good
correspondence with the clinical findings of the patients
affected by neuroblastoma and also of the children with
hypertension.
The levels related with the creatinine excretion must be
evaluated carefully because in the literature (13) a lot
of articles describe the possible interference from diet
(ingestion of meat) (14), drugs (15, 16), analytical varia-
tion (5—7%) and intra-personal fluctuation for younger
children (13). All borderline values should be repeated
routinely.
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Conclusions
Quantification of total urinary catecholamines is a reli-
able means of diagnosis and monitoring of neuro-
blastoma in children. None of these tests are 100% sen-
sitive or specific in tumour detection and all metabolites
should be measured. Catecholamine assays on serial
urine samples of previously diagnosed patients proved
to be helpful as prognostic markers, to identify relapse
and response to chemotherapy.
In our opinion it is necessary to increase standardisation
of these methods and values by using automated pro-
cedures and on-line sample preparation: variation be-
tween-day and sample clean-up should be improved.
This way published reference ranges become more
widely applicable.
References
1. Fitzgibbon MC, Tormey WP. Paediatric reference ranges for
urinary catecholamines/metabolites and their relevance in neu-
roblastoma diagnosis [review article]. Ann Clin Biochem
1994; 31:1-11.
2. Lamedica G, Marchese N, Garaventa A, Canini S, Boni L,
Parodi E, et al. Parametri biochimici per la diagnosi e la pro-
gnosi del neuroblastoma. Giorn It Chim Clin 1989; 14
(N.4):275-87.
3. Candito M, Thyss A, Albertini M, Deville A, Politano S, Mari-
ani R, Chambon P. Methylated catecholanines metabolites for
diagnosis of neuroblastoma. Med Fed Oncol 1992; 20:215-
20.
4. Di Bussolo JM, Gant JR, Kerber D. Instrumental considera-
tions in catecholamines analysis using liquid chromatography
with electrochemical detection. Chromatogr Newslett 1983;
11-1:27-9.
5. Jaffe MZ. Ueber den Niederschlag, welchen Pikrinsäure in
normalem Harn erzeugt und über eine neue Reaction des Krea-
tinins. Physiol Chem 1886; 10:391-400.
6. Abeling NG, van Gennip AH, Overmars H, Voute PA. Simul-
taneous determination of catecholamines and metanephrines in
urine by HPLC with fluorimetric detection. Clin Chim Acta
1984; 137:211-26.
7. Solberg HE. Approved recommendations on the theory of ref-
erence values. Part 5. Statistical treatment of collected refer-
ence values. Determination of reference limits. Clin Chim Acta
1987; 170:813-32; J Clin Chem Clin Biochem 1987;
25:645-56.
8. Altaian DG, Gore SM, Gardner MJ, Pocock SJ. Statistical
guidelines for contributors to medical journals. Ann Clin Bio-
chem 1992; 29:1-8.
9. Parra A, Ramirez del Angel A, Cervantes C, Sanchez M. Uri-
nary excretion of catecholamines in healthy subjects in relation
to body growth. Acta Endocrinol 1980; 94:546-51.
10. Henderson MJ, Heney D, McGinlay JM, Lewis I, Bailey C.
Measurement of dopamine, HVA and HMMA in untimed urine
samples; establishment of age related reference range data in
children. Ann Clin Biochem 1992; 29:162-7.
11. Fitzgibbon MC, FitzGerald RJ, Tormey WP, O'Meara A,
Kenny D. Reference values for urinary HMMA, HVA, nor-
adrenaline, adrenaline and dopamine excretion in children
using random urine samples and HPLC with electrochemical
detection. Ann Clin Biochem 1992; 29:400-4.
12. Rosano TG. Liquid-chromatographic evaluation of age related
changes in the urinary excretion of free catecholamines in pae-
diatric patients. Clin Chem 1984; 30:301-3.
13. O'Meara A, Torrney W, FitzGerald RJ, Fitzgibbon M, Kenny
D. Interpretation of random urinary catecholamines and their
metabolites in neuroblastoma. Acta Paediatr 1994; 83:88-92.
14. Jacobsen FK, Christensen CK, Mogensen CE, Heilskov SC.
Evaluation of kidney function after meals. Lancet 1980; i:319.
15. Payne RB. Creatinine clearance: a redundant clinical investiga-
tion. Ann Clin Biochem 1986; 23:243-50.
16. Van Acker BAG, Koomen GCM, Koopman MG, de Waart DR,
Arisz L. Creatinine clearance during cimetidine administration
for the measurement of glomerular filtration rate. Lancet
1992; 25:492-3.
Received January 29/April 25. 1997
Corresponding author: Dr. Nora Marchese, 1° Laboratorio di
Analisi Chimico-Cliniche, Istituto G. Gaslini, Largo G. Gaslini 5,
1-16147 Geneva, Italy

